April 28th, 2026

The call emphasized several strong strategic and financial positives: a very successful $700M equity raise, underlying net income growth of ~15%, reaffirmed full-year guidance, a detailed $2.7B five-year capital plan with ~80% expected to qualify for regulatory recovery, and concrete progress on QuadVest and other regulatory filings. Offsetting items include EPS dilution from a higher share count leaving EPS flat despite net income growth, rising operating and water production costs, significant near-term project costs (PFAS remediation, Texas investments), and timing/regulatory risk around the QuadVest closing and future Texas rate cases. On balance, the highlights — particularly the oversubscribed equity financing, strong liquidity, affirmed guidance, and visible regulatory recovery mechanisms — materially outweigh the headwinds.

Company Guidance

H2O America reiterated standalone 2026 EPS guidance of $3.08–$3.18 (Q1 GAAP diluted EPS $0.49; adjusted $0.50) and reiterated its 2026–2030 plan targeting a 6%–8% long‑term organic EPS CAGR (non‑linear, aiming at or above the top end using 2025 adjusted EPS of $2.99 as the base), with QuadVest accretion expected beginning in 2028. Management expects full‑year 2026 CapEx of $483 million (Q1 spend $85 million, 18% of the year) and a five‑year 2026–2030 capital plan of $2.7 billion (roughly 80% qualifying for timely regulatory recovery), driving an estimated 13% rate‑base CAGR off a year‑end 2025 rate base of $2.8 billion. Financing posture: a $700 million equity raise (upsized from $550 million, >5x oversubscribed, priced at a 2.6% discount) including a $400 million forward agreement available through 2027, intent to stay out of equity markets through at least YE2027, and anticipated debt issuance of $100–$200 million to fund QuadVest; liquidity includes $370 million in available bank lines and cash equivalents, S&P A‑ rating affirmed, and expected FFO‑to‑debt of ~11%–12% through 2027 (above the 11% downgrade threshold), rising to >12% in 2028 with a longer‑term target toward ~15%+ (A‑flat). Transaction and regulatory timing: QuadVest ratemaking FMV cited at $483.6 million with an expected close in H2 2026, QuadVest active connections >57,200 (up 5% Q1 and 16% in 2025; pipeline net +5,000 YTD despite converting 2,800), Texas share of customers projected to rise from 8% today to 26% by 2029, a combined Texas GRC to be filed early 2027 with new rates effective early 2028, and remaining regulatory items highlighted (e.g., SJWC Williams Station PFAS ion‑exchange capex ~$176M; CT GRC seeks ≈$26M annual revenue to recover ≈$129M of investments; ME GRC requests $9.5M to recover ≈$36M).